Cargando…

P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors

Detalles Bibliográficos
Autores principales: Fey, G, Braciak, TA, Wildenhain, S, Roskopf, CC, Schiller, C, Fenn, N, Schubert, IA, Jacob, U, Hopfner, KP, Oduncu, FS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071944/
http://dx.doi.org/10.1186/2051-1426-2-S2-P14
_version_ 1782322877535617024
author Fey, G
Braciak, TA
Wildenhain, S
Roskopf, CC
Schiller, C
Fenn, N
Schubert, IA
Jacob, U
Hopfner, KP
Oduncu, FS
author_facet Fey, G
Braciak, TA
Wildenhain, S
Roskopf, CC
Schiller, C
Fenn, N
Schubert, IA
Jacob, U
Hopfner, KP
Oduncu, FS
author_sort Fey, G
collection PubMed
description
format Online
Article
Text
id pubmed-4071944
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40719442014-06-27 P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors Fey, G Braciak, TA Wildenhain, S Roskopf, CC Schiller, C Fenn, N Schubert, IA Jacob, U Hopfner, KP Oduncu, FS J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4071944/ http://dx.doi.org/10.1186/2051-1426-2-S2-P14 Text en Copyright © 2014 Fey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Fey, G
Braciak, TA
Wildenhain, S
Roskopf, CC
Schiller, C
Fenn, N
Schubert, IA
Jacob, U
Hopfner, KP
Oduncu, FS
P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title_full P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title_fullStr P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title_full_unstemmed P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title_short P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
title_sort p23. efficient ex vivo lysis of acute myeloid leukaemic (aml) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071944/
http://dx.doi.org/10.1186/2051-1426-2-S2-P14
work_keys_str_mv AT feyg p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT braciakta p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT wildenhains p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT roskopfcc p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT schillerc p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT fennn p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT schubertia p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT jacobu p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT hopfnerkp p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors
AT oduncufs p23efficientexvivolysisofacutemyeloidleukaemicamlcellsmediatedbytriplebodieswithdualtargetingcapabilityinconjunctionwithnaturalkillercellsaseffectors